Fonix secures six new PowerScribe contractsDictation software developer Fonix of Salt Lake City last month signed contracts with six U.S. hospitals for its PowerScribe Radiology speech recognition/dictation system. Fonix licensed the system to
Dictation software developer Fonix of Salt Lake City last month signed contracts with six U.S. hospitals for its PowerScribe Radiology speech recognition/dictation system. Fonix licensed the system to Shands Medical Center in Gainesville, FL, Community General Hospital and Lawrence Hospital in NY, Griffin Hospital in Derby, CT, Citrus Valley Medical Center in Covina, CA, and Ingalls Health System in Cook County, IL. The contracts are worth about $824,000, and Fonix expects to gain additional revenues from ongoing service and maintenance agreements.
The company also announced that it has established a 19-person direct sales and service team in its Healthcare Solutions Group to focus on the PowerScribe product line. Previously part of PowerScribe's North American distributor, The MRC Group, the team captured sales contracts in 1998 totaling $4.1 million. Fonix expects to gain about $2 million of these sales, and will benefit from annual maintenance and service agreements that arise from these and future contracts, according to the Salt Lake City-based firm. Fonix continues to develop PowerScribe Emergency Medicine System and has placed the product in beta sites, according to the company.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.